HIV Vaccine Trials Network

by Alphascript Publishing
State: New
$33.23
VAT included - FREE Shipping
Alphascript Publishing HIV Vaccine Trials Network
Alphascript Publishing - HIV Vaccine Trials Network

Do you like this product? Spread the word!

$33.23 incl. VAT
Only 1 items available Only 1 items available
Delivery: between Friday, June 3, 2022 and Tuesday, June 7, 2022
Sales & Shipping: Dodax

Description

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. The HIV Vaccine Trials Network is a non-profit organization which connects physicians and scientists with activists and community educators for the purpose of conducting clinical trials seeking a safe and effective HIV vaccine. Collaboratively, research professionals and laypeople review potential vaccines for safety, immune response, and efficacy. The HVTN is the only HIV vaccine research network sponsored nationwide by the American government. It also manages the only large-scale HIV vaccine research trial network in Africa. The HVTN collaborates with the Division of Acquired Immunodeficiency Syndrome. Funding comes from the National Institute of Allergy and Infectious Diseases and National Institutes of Health, which oversee DAIDS. HVTN is headquartered at the Fred Hutchinson Cancer Research Center in Seattle. The vaccines being tested come from various producers, both commercial and non-profit. The HVTN is a network for testing vaccines, and while its members may also work in vaccine development for other entities, the mission of the HVTN does not include vaccine design.

Further information

Language:
English
Number of Pages:
80
Editor:
Miller, Frederic P.
Vandome, Agnes F.
McBrewster, John
Media Type:
Softcover
Publisher:
Alphascript Publishing

Master Data

Product Type:
Paperback book
Package Dimensions:
0.23 x 0.15 x 0.01 m; 0.127 kg
GTIN:
09786131636615
DUIN:
R8OATAL9I3K
$33.23
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.